Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
daily_trading_volume_value
market_share59.07%
Current ETH GAS: 0.1-1 gwei
Hot BTC ETF: IBIT
Bitcoin Rainbow Chart : Accumulate
Bitcoin halving: 4th in 2024, 5th in 2028
BTC/USDT$ (0.00%)
banner.title:0(index.bitcoin)
coin_price.total_bitcoin_net_flow_value0
new_userclaim_now
download_appdownload_now
daily_trading_volume_value
market_share59.07%
Current ETH GAS: 0.1-1 gwei
Hot BTC ETF: IBIT
Bitcoin Rainbow Chart : Accumulate
Bitcoin halving: 4th in 2024, 5th in 2028
BTC/USDT$ (0.00%)
banner.title:0(index.bitcoin)
coin_price.total_bitcoin_net_flow_value0
new_userclaim_now
download_appdownload_now
daily_trading_volume_value
market_share59.07%
Current ETH GAS: 0.1-1 gwei
Hot BTC ETF: IBIT
Bitcoin Rainbow Chart : Accumulate
Bitcoin halving: 4th in 2024, 5th in 2028
BTC/USDT$ (0.00%)
banner.title:0(index.bitcoin)
coin_price.total_bitcoin_net_flow_value0
new_userclaim_now
download_appdownload_now
what happened to efsh stock 1847 overview

what happened to efsh stock 1847 overview

This article explains what happened to EFSH stock (the ticker for 1847 Holdings LLC), summarizing the 2024 public offering, later corporate actions and acquisitions, NYSE American delisting determi...
2025-11-12 16:00:00
share
Article rating
4.3
118 ratings

What happened to EFSH stock (1847 Holdings LLC)

Brief lead

As of April 3, 2025, what happened to efsh stock centers on 1847 Holdings LLC’s public-market disruptions: the company’s January 2024 public offering and late-2024 corporate transactions were followed by an NYSE American delisting determination and immediate trading suspension on April 3, 2025, and then steps to move quotation to OTC marketplaces in mid‑2025. This article reviews the company background, ticker and exchange history, a detailed timeline of material events, exchange reasoning, market and shareholder implications, current status as reported, and sources to verify each fact. Readers looking for context on what happened to efsh stock will find the principal documents and practical investor considerations summarized here.

Company background

1847 Holdings LLC (trading under the ticker EFSH on public quotation services) is a microcap public company that has reported operations in consumer-facing service lines and certain specialized business-to-business activities. The company began operating under its current corporate structure prior to its earliest public quotations and used the symbol EFSH as its primary market identifier on public quote services.

As with many small public companies, 1847 Holdings LLC has supplemented operating revenues with capital raises, acquisitions, and equity incentives intended to support growth. Because 1847 Holdings LLC is a microcap issuer, its market capitalization, trading volumes, and investor base have historically been smaller than larger exchanges’ listed issuers, which can make its share price more sensitive to corporate actions, filings, and market commentary.

For readers asking what happened to efsh stock, it helps to know that EFSH is the public ticker representing 1847 Holdings LLC’s common shares and that the company’s market journey in 2024–2025 involved public offerings, acquisitions, corporate governance amendments and ultimately exchange delisting action and a move toward OTC quotation.

Ticker and exchange history

EFSH has historically been quoted on the NYSE American (formerly known as NYSE MKT) when the company met initial listing criteria. Over time the company’s shares experienced low trading prices and reduced liquidity. As of April 3, 2025, NYSE American staff determined an immediate suspension and delisting proceeding for the common shares; that action prompted the company and market participants to pursue quotation alternatives on OTC markets such as the OTCQB and OTC Pink tiers.

A few broad points about tickers and exchanges that help explain the practical differences observed for EFSH:

  • An exchange listing (e.g., NYSE American) typically requires ongoing listing standards for minimum bid price, market capitalization, public float, and governance. When those standards are no longer met, an exchange may start delisting proceedings.
  • OTC markets (OTCQB, OTC Pink) have different quotation and disclosure regimes. When a security moves to OTCQB or OTC Pink, investors often see wider spreads, lower liquidity, and differences in disclosure frequency compared with exchange-listed securities.
  • The ticker symbol EFSH can persist across venues for continuity, but the trading venue determines quoting and many investor protections.

Understanding where EFSH has traded — exchange then OTC — is central to answering what happened to efsh stock and what that means for holders.

Key timeline of events

The following timeline covers the main events that affected EFSH stock from the January 2024 public offering through mid‑2025 transitions.

January 2024 — Public offering announcement and market reaction

As of January 2024, according to company public filings and press disclosures, 1847 Holdings LLC filed to conduct a public offering. The proposed offering size and pricing were disclosed in the filing; reports at the time noted a proposed price per share and an offering of newly issued shares intended to raise capital for operations and strategic initiatives.

Market reaction to the January 2024 offering announcement was negative in the short term. Analysts and market commentators reported downward pressure on the share price driven largely by dilution concerns: when a microcap company issues a substantial number of new shares at a set offering price, existing shareholders can face immediate dilution in ownership percentage and, depending on the perceived use of proceeds, downward pressure on market price.

Reported practical outcomes for EFSH after the Jan 2024 filing included reduced quote levels and heightened volatility. These market responses are common for small issuers announcing dilutive offerings and help explain early 2024 weakness in the security.

Late 2024 — Acquisitions and corporate actions

In late 2024, 1847 Holdings LLC disclosed corporate transactions including an acquisition of assets from CMD Companies (or similar operating entities as disclosed in company SEC filings). The company also reported amendments to purchase agreements and adjustments to corporate governance matters.

As of late 2024, per company 8‑K filings and related disclosures, the firm authorized changes such as increases in authorized shares and amendments to equity incentive plans to support the integration of acquired businesses and to grant management and employee incentives.

These corporate actions had two material market effects that are relevant to what happened to efsh stock:

  • Perceived dilution risk grew because of increased authorized shares and equity awards, which can expand the share count over time if exercised or issued.
  • Integration risk and execution uncertainty around acquisitions can reduce investor confidence in a small issuer, affecting demand for the shares and contributing to price pressure.

Public filings in this period formed part of the narrative that later factored into exchange suitability assessments.

April 3, 2025 — NYSE American delisting proceedings and trading suspension

As of April 3, 2025, NYSE American staff issued a notice that it had determined to commence delisting proceedings under Section 1003(f)(v) of the NYSE American Company Guide. The stated reason in the exchange notice was unsuitability due to a sustained low selling price of the company’s common shares.

The exchange notice indicated that trading of 1847 Holdings LLC common shares was suspended immediately on April 3, 2025. The suspension and delisting determination cited the company’s sustained low selling price as the basis for finding the company unsuitable for continued listing on the exchange.

Under the exchange’s procedural rules, this determination provided 1847 Holdings LLC with the right to respond, request a review by the Listings Qualifications Panel, and submit additional material or a plan to regain suitability. If the exchange ultimately proceeds with delisting after internal review, the exchange would then submit an application to the U.S. Securities and Exchange Commission (SEC) to delist the securities, triggering additional review steps at the federal regulator.

This April 3, 2025 action marks the critical marketplace shift that explains much of what happened to efsh stock: suspension from its listed venue and initiation of a delisting pathway.

April 2025 — Company responses and proposed shareholder actions

Following the April 3, 2025 suspension and delisting determination, 1847 Holdings LLC announced corporate proposals intended to address capital structure and shareholder equity outcome concerns. As reported in the company’s public filings in April 2025, management proposed an exchange offer that would allow holders of common shares to tender or convert their common shares into newly issued Series G preferred shares under specified terms.

Reported terms disclosed by the company included the following material points (as stated in April 2025 filings and press summaries):

  • The Series G preferred shares carried a stated value of $0.15 per share and paid a 15% annual cumulative cash dividend.
  • Series G shares were described as convertible into common shares at a conversion rate equivalent to a $2.40 per common-share conversion price.
  • The company retained an option to redeem Series G preferred shares at a redemption price equal to 110% of the stated value.

These mechanics were intended by management to provide shareholders with an alternative to a forced delisting and to preserve an equity interest with contractual dividend rights and conversion mechanics. The practical economics of accepting such an exchange offer depend materially on the holder’s view of the company’s recovery prospects, the fairness of the conversion terms relative to prevailing market prices, and the shareholder’s liquidity needs.

The company also noted in filings the timeline for any appeal of the exchange’s delisting determination; the standard process allowed 1847 Holdings LLC to request review by the Listings Qualifications Panel within a specified appeal window following the April 3 notice.

Mid–2025 — Transition to OTC markets

After the exchange suspension and the company’s announcement of remedial measures, 1847 Holdings LLC took steps to ensure there would remain a public quotation venue if the NYSE American delisting proceeded. As of mid‑2025 (with press summaries appearing through July 2025), the company reported it had applied or intended to apply for quotation on OTC marketplaces such as the OTCQB and OTC Pink tiers and to notify shareholders once an OTC trading commencement date had been confirmed.

Market summaries in July 2025 reported that EFSH quotations appeared on OTC quote services and that the company was actively informing shareholders about the expected change in trading venue and any conversion/exchange options available to them. The move to OTC was described by market commentators as a standard step for issuers facing delisting from a national exchange and wanting to retain a transparent public quotation, albeit under a different market structure.

The combined effect of the suspension, the exchange offer, and the OTC transition explains the core answer to what happened to efsh stock: the security moved from an exchange-listed status into delisting proceedings and then onto OTC quotation, with material corporate transactions and capital-raising steps occurring along the way.

Reasons given for trading changes

The exchange and company filings identify the primary reasons for the trading changes. The NYSE American’s formal reason, stated on April 3, 2025, was a sustained low selling price that rendered the company unsuitable for continued listing under Section 1003(f)(v) of the NYSE American Company Guide.

Other contributing factors that commentators and filings cited include:

  • Dilutive capital raises and increased authorized shares announced in 2024 and early 2025, which elevated investor concerns about share count expansion.
  • Corporate transactions and acquisitions in late 2024 that introduced execution risk and uncertainty about near-term financial performance.
  • Low liquidity and reduced daily trading volumes consistent with microcap securities, which can make it difficult to meet exchange-maintained standards and sustain a viable bid price.

Taken together, these structural and corporate events influenced the exchange’s suitability assessment and underpinned the market outcomes that answer what happened to efsh stock.

Market and investor reaction

Investor reaction to the April 3, 2025 suspension and the surrounding corporate activity was characterized by increased volatility, a downward repricing of the shares, and concerns about liquidity.

Specific observed reactions included:

  • Immediate loss of benefits tied to a national-exchange listing: inclusion in certain market data feeds, perceived listing prestige, and institutional access that often accompanies exchange-traded securities.
  • Reported share-price declines and intraday volatility following the delisting notice and during the period when the exchange offer terms were disclosed. In microcap markets, announcements that might signal dilution or delisting typically depress prices more than similar announcements for larger issuers.
  • Commentary from market observers describing the security as entering penny-stock/microcap territory on OTC services, with attendant concerns about wider spreads, fewer market makers, and less regular liquidity.

These reactions align with typical outcomes when a company’s shares are suspended by an exchange and the company moves to OTC quotation. For holders asking what happened to efsh stock, the practical answer is that market access and liquidity were materially reduced and the risk profile of holding the shares changed significantly.

Regulatory, procedural, and shareholder implications

Regulatory and procedural steps after a delisting determination follow defined processes. Key elements shareholders should understand include:

  • Appeal and review: After an exchange delisting determination, the issuer usually has the right to request review by the exchange’s Listings Qualifications Panel within a prescribed timeframe. If the issuer appeals, the Panel reviews submissions and may restore listing, impose conditions, or uphold the delisting determination.
  • SEC involvement: If the exchange continues with a delisting, the exchange will apply to the SEC for approval. The SEC then reviews the exchange’s application; the issuer and third parties may submit comments.
  • Effect on trading: While appeals and SEC processes proceed, trading may remain suspended (as it was immediately on April 3, 2025 for EFSH). Post-delisting, the issuer commonly seeks quotation on OTC markets to preserve public trading.

Practical implications for shareholders include:

  • Lower liquidity and wider spreads on OTC markets compared to national exchanges.
  • Potential changes in disclosure cadence: while public companies still file reports with the SEC, the scope and cadence of market-maker interest and coverage often decrease with OTC quotation.
  • The economics of corporate proposals: shareholders faced a decision about whether to accept the company’s exchange offer into Series G preferred shares. The practical conversion and dividend mechanics (e.g., $0.15 stated value, 15% annual dividend, conversion at $2.40) determine whether accepting an offer is suitable for a holder, but such an evaluation requires access to up-to-date disclosures and personal financial considerations.

This procedural summary is intended to explain the steps and consequences that followed what happened to efsh stock.

Current status (as of latest public reporting)

As of July 2025, the principal public facts that answer what happened to efsh stock are:

  • NYSE American issued a delisting determination and suspended trading of 1847 Holdings LLC common shares on April 3, 2025, citing sustained low selling price as the basis. (Source: NYSE American notice dated April 3, 2025.)
  • The company publicly disclosed an exchange offer in April 2025 proposing conversion of common shares into Series G preferred shares with stated terms (stated value $0.15, 15% cumulative dividend, conversion into common at a $2.40 conversion price, company redemption option at 110% of stated value). (Source: Company SEC Form 8‑K filings in April 2025.)
  • In mid‑2025 the company applied for OTC quotation and notified shareholders it would pursue OTCQB/OTC Pink quotation to restore public trading; market quote services subsequently showed EFSH quotations on OTC tiers. (Source: mid‑2025 press summaries and market quotation services.)

Because market quotations and filings change in real time, readers should check the company’s SEC filings (Form 8‑K series), any exchange notices, and current OTC quote services for the latest status on EFSH trading, price, and volume.

Risks and investor considerations

For holders and prospective buyers considering what happened to efsh stock, the following risk points are relevant:

  • Liquidity risk: Post-delisting and during OTC quotation, average daily trading volume typically falls, making it harder to buy or sell meaningful positions without moving the market.
  • Price risk: The share price may decline further if market confidence weakens or if further dilution occurs through authorized share increases or equity incentives.
  • Dilution risk: Proposed exchange offers and increased authorized shares can dilute existing ownership and change per-share economics.
  • Disclosure and transparency: Although SEC reporting obligations may remain, market-maker coverage and analyst attention often decline for OTC securities, reducing the publicly available interpretive analysis.

Prudent steps for investors include reviewing the company’s recent SEC filings (especially Forms 8‑K and S‑1/A if applicable), consulting with a licensed broker/dealer about the practicalities of trading OTC securities, and monitoring official exchange notices. For investors interested in secure access to multiple markets or in managing custody and transfers, Bitget provides trading and wallet services that may offer operational convenience; users should evaluate platform features, fees, and availability for small-cap and OTC securities where applicable.

Note: This article is factual and educational in nature and does not constitute investment advice.

See also

  • Delisting procedures and appeals process for national exchanges
  • OTC Markets tier distinctions: OTCQB vs OTC Pink
  • How exchange listings work and listing standards
  • Penny-stock and microcap risk considerations

References and sources

As of the cited dates below, the principal public sources used to compile this article included:

  • NYSE American notice of delisting proceedings dated April 3, 2025 (NYSE American staff determination to commence delisting proceedings citing low selling price under Section 1003(f)(v)).
  • Company SEC filings (Form 8‑K) in January 2024 (public offering disclosures), late 2024 (acquisition and governance amendments), and April 2025 (exchange offer terms and responses to delisting notice). These filings contain the detailed numeric terms cited above.
  • Press summaries and market reports from April–July 2025 summarizing EFSH’s move to OTC quotation and reporting on exchange-offer mechanics (examples include mid‑2025 coverage in market news services and microcap-focused outlets).
  • Market quote services and OTC quotation screens showing EFSH quotes on OTCQB/OTC Pink tiers in mid‑2025.

Readers should verify facts by consulting the primary documents: the company’s SEC filings and the official NYSE American exchange notice. Primary documents are the authoritative record for dates, prices, and procedural deadlines.

Notes for editors and contributors

  • Keep this article current by checking the company’s most recent SEC filings (Form 8‑K, Forms 10‑Q/10‑K if applicable), NYSE American or exchange notices, and real‑time OTC quotation feeds.
  • When adding detailed numeric data (e.g., final share counts, market caps, daily volume figures, or appeal outcomes), cite the specific filing or public exchange notice and include the document date.
  • Maintain neutrality: avoid speculation about management intent or market outcomes beyond what filings and official notices state.
  • Use primary documents for precise language when updating legal or contract terms (for example, exact conversion mechanics, redemption price, and appeal deadlines).

Further practical note: for investors seeking operational access to markets or custody, Bitget provides exchange services and Bitget Wallet for Web3 asset management. For questions about trading mechanics on OTC securities using retail brokerage services, consult a licensed broker/dealer for guidance specific to your jurisdiction and account type.

The content above has been sourced from the internet and generated using AI. For high-quality content, please visit Bitget Academy.
Buy crypto for $10
Buy now!

Trending assets

Assets with the largest change in unique page views on the Bitget website over the past 24 hours.

Popular cryptocurrencies

A selection of the top 12 cryptocurrencies by market cap.